One Global Service Provider Ltd
Incorporated in 1992, One Global Service
Provider Ltd is in the business of healthcare services[1]
- Market Cap ₹ 799 Cr.
- Current Price ₹ 409
- High / Low ₹ 790 / 327
- Stock P/E 12.8
- Book Value ₹ 83.8
- Dividend Yield 0.24 %
- ROCE 87.0 %
- ROE 65.3 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 97.2% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 59.0%
Cons
- Promoter holding has decreased over last quarter: -2.39%
- Company has high debtors of 159 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Part of BSE Healthcare
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 2 | 0 | 4 | 6 | 18 | 63 | 147 | 498 | 444 | |
| Sales growth | +627% | -100% | +66% | +198% | +248% | +133% | +239% | +43% | |||||
| 0 | 0 | 0 | 0 | 2 | 0 | 1 | 5 | 16 | 53 | 122 | 405 | 361 | |
| Operating Profit | -0 | -0 | -0 | 0 | 0 | -0 | 2 | 1 | 2 | 10 | 25 | 93 | 84 |
| OPM % | 73% | 14% | 68% | 23% | 9% | 15% | 17% | 19% | 19% | ||||
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Profit before tax | -0 | -0 | -0 | 0 | 0 | -0 | 2 | 1 | 1 | 10 | 25 | 93 | 83 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -3% | -1% | 25% | 26% | 25% | |
| -0 | -0 | -0 | 0 | 0 | -0 | 2 | 1 | 1 | 7 | 18 | 70 | 62 | |
| EPS in Rs | -0.14 | -0.11 | -0.13 | 0.27 | 0.38 | -0.42 | 3.28 | 1.48 | 1.94 | 10.01 | 26.00 | 35.56 | 31.95 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 10% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 167% |
| 3 Years: | 202% |
| TTM: | 43% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 97% |
| 5 Years: | 97% |
| 3 Years: | 269% |
| TTM: | 42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 55% |
| 5 Years: | 75% |
| 3 Years: | 104% |
| 1 Year: | -6% |
| Return on Equity | |
|---|---|
| 10 Years: | 53% |
| 5 Years: | 56% |
| 3 Years: | 59% |
| Last Year: | 65% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 20 | 20 | 20 |
| Reserves | -5 | -5 | -5 | -5 | -4 | -5 | -2 | -1 | 0 | 7 | 52 | 122 | 144 |
| 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 2 | 1 | 0 | 1 | 2 | 5 | 17 | 34 | 113 | 98 | |
| Total Liabilities | 3 | 3 | 3 | 5 | 4 | 3 | 6 | 8 | 13 | 32 | 106 | 254 | 262 |
| 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | |
| CWIP | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 0 | 0 | 0 | 2 | 1 | 0 | 3 | 5 | 9 | 28 | 104 | 252 | 260 | |
| Total Assets | 3 | 3 | 3 | 5 | 4 | 3 | 6 | 8 | 13 | 32 | 106 | 254 | 262 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0 | -0 | -0 | -0 | 0 | -0 | 1 | 1 | 0 | 1 | 14 | -11 | |
| 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -0 | -0 | -0 | -0 | |
| 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | -1 | -0 | |
| Net Cash Flow | -0 | 0 | -0 | -0 | 0 | 0 | 0 | -0 | -0 | 1 | 14 | -11 |
| Free Cash Flow | -0 | -0 | -0 | -0 | 0 | -0 | -0 | -0 | -0 | 1 | 14 | -11 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 90% | 162% | 111% | -32% | 141% | 6% | 45% | 38% | 8% | 12% | 67% | 12% |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 365 | 149 | 0 | 242 | 164 | 152 | 134 | 159 | ||||
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
| Days Payable | 91 | |||||||||||
| Cash Conversion Cycle | 365 | 149 | 0 | 242 | 164 | 152 | 134 | 68 | ||||
| Working Capital Days | 421 | 37 | 149 | 135 | 76 | 57 | 59 | 77 | ||||
| ROCE % | -4% | -3% | -3% | 6% | 9% | -11% | 60% | 18% | 20% | 85% | 56% | 87% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sale of Services as % of Total Revenue % |
|
||||||||||
| Number of Permanent Employees count |
|||||||||||
| Healthcare Services Share of Total Turnover % |
|||||||||||
Extracted by Screener AI
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Please find attached intimation regarding newspaper publication of Postal Ballot under regulation 30 & 47 of SEBI (LODR), 2015
-
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
- Postal ballot for CMD remuneration/reappointment, loan-to-equity conversion, and independent director appointment; voting from 6 Nov to 5 Dec 2026.
-
Revised Outcome Of Board Meeting Held On Wednesday, 04Th November, 2026
- Corrected appointment date of Mr. Padmakar Pandit as Additional Independent Director, effective 4 November 2026 for five years.
-
Announcement under Regulation 30 (LODR)-Change in Directorate
- Q2 FY27 results announced; board approved CMD remuneration, 5-year reappointment, and independent director appointment.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1]
The company acts as a one-stop supplier
to the healthcare industry: Medical and diagnostic equipment, hospital furniture,
high-end laboratory analysers, and reagents, consumables, and chemicals. It also sells
allied software (LIS, MIS, HIMS) and operates laboratories providing diagnostic, preventive-care, and population-screening services